FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to derivatives of pyrazine of the general formula (I): and their salts wherein R1 represents hydrogen atom or halogen atom; R2 represents hydrogen atom or protected or unprotected group of monophosphoric, diphosphoric or triphosphoric acid; R3, R4, R5 and R6 can be similar or different and represent hydrogen atom, halogen atom, substituted or unsubstituted, protected or unprotected hydroxyl group or amino-group; or R4 and R6 taken in common form a simple bond; A represents oxygen atom or methylene group; n = 0 or 1; Y represents oxygen atom pr NH-group. Compounds elicit the excellent antiviral activity and useful as a therapeutic agent in treatment of viral infections. Also, invention describes a pharmaceutical composition based on compounds of the formula (I) and derivatives of fluoropyrazine carboxamide as intermediate compounds used in synthesis of compounds of the formula (I).
EFFECT: valuable medicinal properties of compounds and pharmaceutical composition.
13 cl, 6 tbl, 57 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF PYRAZINE AND THEIR SALTS, PHARMACEUTICAL COMPOSITION COMPRISING THESE COMPOUNDS | 2001 |
|
RU2259368C2 |
ORGANIC AMINE SALT OF 6-FLUORO-3-HYDROXY-2-PYRAZINE CARBONITRILE AND METHOD FOR PRODUCTION THEREOF | 2008 |
|
RU2470924C2 |
PYRAZINO[2,3-d]ISOXAZOLE DERIVATIVE | 2011 |
|
RU2570802C2 |
TRICYCLIC COMPOUND AND ITS PHARMACEUTICAL APPLICATION | 2007 |
|
RU2456278C2 |
HETEROCYCLIC COMPOUND | 2006 |
|
RU2382781C2 |
PRODRUG OF TRIAZOLONE COMPOUND | 2011 |
|
RU2581369C2 |
BENZOPYRANE AND BENZOCONDENSED COMPOUNDS, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION AND A METHOD OF INHIBITION | 1995 |
|
RU2128655C1 |
CONDENSED CYCLIC COMPOUNDS | 2007 |
|
RU2444521C2 |
IMIDAZOPYRIDINE COMPOUND | 2005 |
|
RU2373206C2 |
NEW METHOD FOR INHIBITION OF VIRUS GROWTH AND/OR VIRULICIDE METHOD AND NOVEL ANALOG OF PYRAZINE NUCLEOTIDE OR PYRAZINE NUCLEOSIDE | 2002 |
|
RU2292894C2 |
Authors
Dates
2007-04-20—Published
2001-02-14—Filed